Top Markets
Coin of the day
AroCell AB (publ) AroCell AB (publ)

AroCell AB (publ)

AROC
Rang in Aktien #31795
AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on... AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.
Aktienkurs
$0.05234265
Zuletzt synchronisiert: 2025-06-23
Marktkapitalisierung
$12.06M
Veränderung (1 Tag)
-3.01%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel AroCell AB (publ) (AROC)

Kategorie

Kursverlauf für AroCell AB (publ) (AROC)
Höchster Schlusskurs: $0.06 am 2025-06-01

Niedrigster Schlusskurs: $0.66 am 2011-05-01
Kursverlauf der Aktie von AroCell AB (publ) von 2011 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 52.95%
2024 -12.09%
2023 -20.98%
2022 -57.24%
2021 -56.70%
2020 105.13%
2019 -47.78%
2018 -46.79%
2017 -31.41%
2016 -39.64%
2015 56.69%
2014 -37.92%
2013 65.83%
2012 40.59%
2011 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$586.41 20.28%
US
$202.37 -3.18%
US
$24.23 79.49%
CN
$314.26 95.01%
US
$544.68 -14.61%
US